These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 27162011

  • 1. 1-(5-Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase: bioisosteric replacement of the carboxylic acid moiety.
    Althaus J, Hake T, Hanekamp W, Lehr M.
    J Enzyme Inhib Med Chem; 2016; 31(sup1):131-140. PubMed ID: 27162011
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A₂α and fatty acid amide hydrolase: Effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability.
    Sundermann T, Fabian J, Hanekamp W, Lehr M.
    Bioorg Med Chem; 2015 May 15; 23(10):2579-92. PubMed ID: 25862211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.
    Ludwig J, Bovens S, Brauch C, Elfringhoff AS, Lehr M.
    J Med Chem; 2006 Apr 20; 49(8):2611-20. PubMed ID: 16610804
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A2α: Effect of substituents at the indole 3-position on activity, solubility, and metabolic stability.
    Arnsmann M, Hanekamp W, Elfringhoff AS, Lehr M.
    Eur J Med Chem; 2017 Jan 05; 125():1107-1114. PubMed ID: 27810597
    [Abstract] [Full Text] [Related]

  • 13. 1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability.
    Bovens S, Schulze Elfringhoff A, Kaptur M, Reinhardt D, Schäfers M, Lehr M.
    J Med Chem; 2010 Dec 09; 53(23):8298-308. PubMed ID: 21067218
    [Abstract] [Full Text] [Related]

  • 14. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
    Deplano A, Cipriano M, Moraca F, Novellino E, Catalanotti B, Fowler CJ, Onnis V.
    J Enzyme Inhib Med Chem; 2019 Dec 09; 34(1):562-576. PubMed ID: 30688118
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2α inhibitors.
    Tomoo T, Nakatsuka T, Katayama T, Hayashi Y, Fujieda Y, Terakawa M, Nagahira K.
    J Med Chem; 2014 Sep 11; 57(17):7244-62. PubMed ID: 25102418
    [Abstract] [Full Text] [Related]

  • 17. Investigations on the metabolic stability of cytosolic phospholipase A2α inhibitors with 1-indolylpropan-2-one structure.
    Fabian J, Hanekamp W, Thomas MH, Olivier JL, Lehr M.
    Chem Biol Interact; 2013 Nov 25; 206(2):356-63. PubMed ID: 24120545
    [Abstract] [Full Text] [Related]

  • 18. Design and synthesis of 3-pyrrol-3-yl-3H-isobenzofuran-1-ones as inhibitors of human cytosolic phospholipase A2alpha.
    Hess M, Schulze Elfringhoff A, Lehr M.
    J Enzyme Inhib Med Chem; 2008 Dec 25; 23(6):946-57. PubMed ID: 18608744
    [Abstract] [Full Text] [Related]

  • 19. Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents.
    Soubhye J, van Antwerpen P, Dufrasne F.
    Curr Med Chem; 2018 Dec 25; 25(21):2418-2447. PubMed ID: 29345571
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.